MEVAC is an American-Egyptian animal-health company specialising in veterinary vaccine development and manufacturing.
Its facilities handle research, production, packaging and distribution of live and inactivated vaccines for poultry, livestock and aquaculture.
The company operates multiple manufacturing sites and advanced production lines under internationally recognised quality standards.
Its New Salhia industrial complex includes modern manufacturing, research, development and quality-control facilities serving local and international markets.